Predictive value of serum anti-C1q antibody levels in experimental autoimmune myasthenia gravis

Erdem Tüzün, Shamsher S. Saini, Sidharth Ghosh, Julie Rowin, Matthew N. Meriggioli, Premkumar Christadoss

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

Components of the complement cascade and circulating immune complexes play important roles in both experimental autoimmune myasthenia gravis and myasthenia gravis in humans. Thus far, no serological factor has been identified to predict the clinical severity of either myasthenia gravis. Upon immunization with acetylcholine receptor, levels of complement factors C1q, C3 and CIC increase with time in sera from C57BL/6 (B6) mice. Both these and plasma samples from myasthenia gravis patients also contain anti-C1q antibodies. The serum levels of anti-C1q antibodies but not C1q, C3 and CIC are significantly correlated with the clinical severity in the experimental myasthenia mice. However, this correlation is not observed in myasthenia gravis patients.

Original languageEnglish (US)
Pages (from-to)137-143
Number of pages7
JournalNeuromuscular Disorders
Volume16
Issue number2
DOIs
StatePublished - Feb 2006

Fingerprint

Autoimmune Experimental Myasthenia Gravis
Myasthenia Gravis
Anti-Idiotypic Antibodies
Serum
Complement C1q
Cholinergic Receptors
Antigen-Antibody Complex
Immunization

Keywords

  • Anti-C1q antibody
  • Autoimmunity
  • Circulating immune complexes
  • Experimental autoimmune myasthenia gravis
  • Myasthenia gravis

ASJC Scopus subject areas

  • Clinical Neurology
  • Pediatrics, Perinatology, and Child Health
  • Developmental Neuroscience
  • Neurology

Cite this

Tüzün, E., Saini, S. S., Ghosh, S., Rowin, J., Meriggioli, M. N., & Christadoss, P. (2006). Predictive value of serum anti-C1q antibody levels in experimental autoimmune myasthenia gravis. Neuromuscular Disorders, 16(2), 137-143. https://doi.org/10.1016/j.nmd.2005.11.005

Predictive value of serum anti-C1q antibody levels in experimental autoimmune myasthenia gravis. / Tüzün, Erdem; Saini, Shamsher S.; Ghosh, Sidharth; Rowin, Julie; Meriggioli, Matthew N.; Christadoss, Premkumar.

In: Neuromuscular Disorders, Vol. 16, No. 2, 02.2006, p. 137-143.

Research output: Contribution to journalArticle

Tüzün, E, Saini, SS, Ghosh, S, Rowin, J, Meriggioli, MN & Christadoss, P 2006, 'Predictive value of serum anti-C1q antibody levels in experimental autoimmune myasthenia gravis', Neuromuscular Disorders, vol. 16, no. 2, pp. 137-143. https://doi.org/10.1016/j.nmd.2005.11.005
Tüzün, Erdem ; Saini, Shamsher S. ; Ghosh, Sidharth ; Rowin, Julie ; Meriggioli, Matthew N. ; Christadoss, Premkumar. / Predictive value of serum anti-C1q antibody levels in experimental autoimmune myasthenia gravis. In: Neuromuscular Disorders. 2006 ; Vol. 16, No. 2. pp. 137-143.
@article{cc2268afb25944cb93be559ea4ac6ae1,
title = "Predictive value of serum anti-C1q antibody levels in experimental autoimmune myasthenia gravis",
abstract = "Components of the complement cascade and circulating immune complexes play important roles in both experimental autoimmune myasthenia gravis and myasthenia gravis in humans. Thus far, no serological factor has been identified to predict the clinical severity of either myasthenia gravis. Upon immunization with acetylcholine receptor, levels of complement factors C1q, C3 and CIC increase with time in sera from C57BL/6 (B6) mice. Both these and plasma samples from myasthenia gravis patients also contain anti-C1q antibodies. The serum levels of anti-C1q antibodies but not C1q, C3 and CIC are significantly correlated with the clinical severity in the experimental myasthenia mice. However, this correlation is not observed in myasthenia gravis patients.",
keywords = "Anti-C1q antibody, Autoimmunity, Circulating immune complexes, Experimental autoimmune myasthenia gravis, Myasthenia gravis",
author = "Erdem T{\"u}z{\"u}n and Saini, {Shamsher S.} and Sidharth Ghosh and Julie Rowin and Meriggioli, {Matthew N.} and Premkumar Christadoss",
year = "2006",
month = "2",
doi = "10.1016/j.nmd.2005.11.005",
language = "English (US)",
volume = "16",
pages = "137--143",
journal = "Neuromuscular Disorders",
issn = "0960-8966",
publisher = "Elsevier Limited",
number = "2",

}

TY - JOUR

T1 - Predictive value of serum anti-C1q antibody levels in experimental autoimmune myasthenia gravis

AU - Tüzün, Erdem

AU - Saini, Shamsher S.

AU - Ghosh, Sidharth

AU - Rowin, Julie

AU - Meriggioli, Matthew N.

AU - Christadoss, Premkumar

PY - 2006/2

Y1 - 2006/2

N2 - Components of the complement cascade and circulating immune complexes play important roles in both experimental autoimmune myasthenia gravis and myasthenia gravis in humans. Thus far, no serological factor has been identified to predict the clinical severity of either myasthenia gravis. Upon immunization with acetylcholine receptor, levels of complement factors C1q, C3 and CIC increase with time in sera from C57BL/6 (B6) mice. Both these and plasma samples from myasthenia gravis patients also contain anti-C1q antibodies. The serum levels of anti-C1q antibodies but not C1q, C3 and CIC are significantly correlated with the clinical severity in the experimental myasthenia mice. However, this correlation is not observed in myasthenia gravis patients.

AB - Components of the complement cascade and circulating immune complexes play important roles in both experimental autoimmune myasthenia gravis and myasthenia gravis in humans. Thus far, no serological factor has been identified to predict the clinical severity of either myasthenia gravis. Upon immunization with acetylcholine receptor, levels of complement factors C1q, C3 and CIC increase with time in sera from C57BL/6 (B6) mice. Both these and plasma samples from myasthenia gravis patients also contain anti-C1q antibodies. The serum levels of anti-C1q antibodies but not C1q, C3 and CIC are significantly correlated with the clinical severity in the experimental myasthenia mice. However, this correlation is not observed in myasthenia gravis patients.

KW - Anti-C1q antibody

KW - Autoimmunity

KW - Circulating immune complexes

KW - Experimental autoimmune myasthenia gravis

KW - Myasthenia gravis

UR - http://www.scopus.com/inward/record.url?scp=31944438299&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=31944438299&partnerID=8YFLogxK

U2 - 10.1016/j.nmd.2005.11.005

DO - 10.1016/j.nmd.2005.11.005

M3 - Article

C2 - 16427283

AN - SCOPUS:31944438299

VL - 16

SP - 137

EP - 143

JO - Neuromuscular Disorders

JF - Neuromuscular Disorders

SN - 0960-8966

IS - 2

ER -